Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 7/20 | 0.36 |
| ▸ | ESR2 | Q92731 | 6/20 | 0.36 |
| ▸ | PDCD1 | Q15116 | 1/20 | 0.36 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | PGR | P06401 | 1/20 | 0.33 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.33 |
| ▸ | AR | P10275 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | DRD1 | P21728 | 1/20 | 0.33 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.33 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1002008 | 1.00 | ESR1 (0.36) | ESR1ESR2PDCD1CD274CYP2C9 | |
| SCHEMBL472087 | 0.85 | ESR1 (0.31) | ESR1ESR2ALDH1A1KDM4E | |
| SCHEMBL472176 | 0.85 | ESR1 (0.31) | ESR1ESR2ALDH1A1KDM4E | |
| SCHEMBL4432626 | 0.85 | ESR1 (0.39) | ESR1ESR2PDCD1CD274CYP2C9 | |
| SCHEMBL8767421 | 0.79 | — | — | |
| SCHEMBL20473388 | 0.76 | ESR1 (0.40) | ESR1ESR2PDCD1CD274CYP2C9 | |
| SCHEMBL20473389 | 0.76 | ESR1 (0.40) | ESR1ESR2PDCD1CD274CYP2C9 | |
| SCHEMBL14325806 | 0.75 | ESR1 (0.35) | ESR1ESR2PDCD1CD274CYP2C9 | |
| SCHEMBL30206999 | 0.72 | ESR1 (0.42) | ESR1ESR2PDCD1CD274CYP2C9 | |
| SCHEMBL5670868 | 0.70 | ESR1 (0.40) | ESR1ESR2PDCD1CD274CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8993791-B2 | Process for producing epoxy compounds | SHOWA DENKO K.K. (JP) | 2015-03-31 | — | — | US | disclosed |
| EP-2383264-B1 | EPOXY COMPOUND PRODUCTION METHOD | SHOWA DENKO KK (JP) | 2015-03-04 | — | — | EP | disclosed |
| US-20120302775-A1 | PROCESS FOR PRODUCING EPOXY COMPOUNDS | SHOWA DENKO K.K. (JP) | 2012-11-29 | — | — | US | disclosed |
| EP-2518061-A1 | PROCESS FOR PRODUCTION OF EPOXY COMPOUND | Showa Denko K.K. (JP) | 2012-10-31 | — | — | EP | disclosed |
| EP-2383264-A1 | EPOXY COMPOUND PRODUCTION METHOD | Showa Denko K.K. (JP) | 2011-11-02 | — | — | EP | disclosed |
| US-4180405-A | COLOR-FORMING LACTONES OR SPIROPYRANS WITH CYCLIC POLYKETO COLOR PRECURSOR | GRAPHIC CONTROLS CORPORATION (US) | 1979-12-25 | — | — | US | disclosed |
| US-4097288-A | Heat sensitive recording composition containing a complexed phenolics and a spiropyran or leuco lactone | GRAPHIC CONTROLS CORPORATION | 1978-06-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120302775-A1 | PROCESS FOR PRODUCING EPOXY COMPOUNDS | AOX1, EPX, CYP2E1 | ESR1 159/4885ESR2 150/4885PDCD1 3683/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.